Literature DB >> 15243998

Peptide aptamers: tools for biology and drug discovery.

Margaret Crawford1, Rob Woodman, Paul Ko Ferrigno.   

Abstract

Peptide aptamer technology is relatively youthful. It has the advantage over existing techniques that the reagents identified are designed for expression in eukaryotic cells. This allows the construction of molecular tools that allow the logic of genetics, from knockouts to extragenic suppressors, to be applied to studies of proteins in tissue culture cells. Until recently, the available tools have limited our understanding of cell biology. The same limitation restricts out ability to validate the numerous candidate drug targets emerging from genome-wide approaches to cellular biology. Peptide aptamers represent a stride forwards in the evolution of a modular, molecular tool kit for cell biology and for drug target validation. The authors predict that they will also play a role in the transition from genomic to proteomic microarray technology.

Mesh:

Substances:

Year:  2003        PMID: 15243998     DOI: 10.1093/bfgp/2.1.72

Source DB:  PubMed          Journal:  Brief Funct Genomic Proteomic        ISSN: 1473-9550


  12 in total

1.  Peptide aptamers that bind to a geminivirus replication protein interfere with viral replication in plant cells.

Authors:  Luisa Lopez-Ochoa; Jorge Ramirez-Prado; Linda Hanley-Bowdoin
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

Review 2.  Peptide aptamers: development and applications.

Authors:  Sergey Reverdatto; David S Burz; Alexander Shekhtman
Journal:  Curr Top Med Chem       Date:  2015       Impact factor: 3.295

3.  Peptide aptamers that bind to geminivirus replication proteins confer a resistance phenotype to tomato yellow leaf curl virus and tomato mottle virus infection in tomato.

Authors:  Maria Ines Reyes; Tara E Nash; Mary M Dallas; J Trinidad Ascencio-Ibáñez; Linda Hanley-Bowdoin
Journal:  J Virol       Date:  2013-07-03       Impact factor: 5.103

Review 4.  Aptamer and its applications in neurodegenerative diseases.

Authors:  Jing Qu; Shuqing Yu; Yuan Zheng; Yan Zheng; Hui Yang; Jianliang Zhang
Journal:  Cell Mol Life Sci       Date:  2016-08-25       Impact factor: 9.261

5.  Targeting inhibition of GluR1 Ser845 phosphorylation with an RNA aptamer that blocks AMPA receptor trafficking.

Authors:  Yingmiao Liu; Qi-An Sun; Qiang Chen; Tong H Lee; Yangzhong Huang; William C Wetsel; Gregory A Michelotti; Bruce A Sullenger; Xiuwu Zhang
Journal:  J Neurochem       Date:  2008-11-12       Impact factor: 5.546

Review 6.  Development of proteomics-based fungicides: new strategies for environmentally friendly control of fungal plant diseases.

Authors:  Francisco Javier Fernández Acero; María Carbú; Mohamed Rabie El-Akhal; Carlos Garrido; Victoria E González-Rodríguez; Jesús M Cantoral
Journal:  Int J Mol Sci       Date:  2011-01-21       Impact factor: 5.923

7.  Nanotechnology-mediated targeting of tumor angiogenesis.

Authors:  Deboshri Banerjee; Rania Harfouche; Shiladitya Sengupta
Journal:  Vasc Cell       Date:  2011-01-31

8.  Combinatorial library of improved peptide aptamers, CLIPs to inhibit RAGE signal transduction in mammalian cells.

Authors:  Sergey Reverdatto; Vivek Rai; Jing Xue; David S Burz; Ann Marie Schmidt; Alexander Shekhtman
Journal:  PLoS One       Date:  2013-06-13       Impact factor: 3.240

9.  Electrical protein detection in cell lysates using high-density peptide-aptamer microarrays.

Authors:  David Evans; Steven Johnson; Sophie Laurenson; A Giles Davies; Paul Ko Ferrigno; Christoph Wälti
Journal:  J Biol       Date:  2008

10.  Peptide aptamers define distinct EB1- and EB3-binding motifs and interfere with microtubule dynamics.

Authors:  Karolina Leśniewska; Emma Warbrick; Hiroyuki Ohkura
Journal:  Mol Biol Cell       Date:  2014-01-29       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.